Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa

Herpes simplex virus (HSV) is sexually transmitted via the anogenital mucosa where it initially infects epidermal keratinocytes and mononuclear phagocytes (MNPs). It then spreads to the dorsal root ganglion via sensory nerve endings, to remain latent for life with periodic reactivation. Currently, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Hafsa Rana, Naomi R. Truong, Dona R. Sirimanne, Anthony L. Cunningham
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/11/1790
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850267106755477504
author Hafsa Rana
Naomi R. Truong
Dona R. Sirimanne
Anthony L. Cunningham
author_facet Hafsa Rana
Naomi R. Truong
Dona R. Sirimanne
Anthony L. Cunningham
author_sort Hafsa Rana
collection DOAJ
description Herpes simplex virus (HSV) is sexually transmitted via the anogenital mucosa where it initially infects epidermal keratinocytes and mononuclear phagocytes (MNPs). It then spreads to the dorsal root ganglion via sensory nerve endings, to remain latent for life with periodic reactivation. Currently, there is no cure or vaccine. Initial or recurrent HSV infection can produce serious complications and mediate acquisition of HIV. This review outlines the initial events after the HSV infection of human anogenital mucosa to determine the optimal window to target the virus before it becomes latent. After infection, HSV spreads rapidly within the mid-layers of epidermal keratinocytes in the explanted human inner foreskin. Infected cells produce chemokines, which modulate nectin-1 distribution on the surface of adjacent keratinocytes, facilitating viral spread. Epidermal Langerhans cells and dendritic cells become infected with HSV followed by a “viral relay” to dermal MNPs, which then present viral antigen to T cells in the dermis or lymph nodes. These data indicate the need for interruption of spread within 24 h by diffusible vaccine-induced mediators such as antiviral cytokines from resident immune cells or antibodies. Intradermal/mucosal vaccines would need to target the relevant dermal MNPs to induce HSV-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells.
format Article
id doaj-art-85a962a98f954dafb7737d1b0559da3b
institution OA Journals
issn 1999-4915
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-85a962a98f954dafb7737d1b0559da3b2025-08-20T01:53:56ZengMDPI AGViruses1999-49152024-11-011611179010.3390/v16111790Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and MucosaHafsa Rana0Naomi R. Truong1Dona R. Sirimanne2Anthony L. Cunningham3Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, NSW 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, NSW 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, NSW 2145, AustraliaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, NSW 2145, AustraliaHerpes simplex virus (HSV) is sexually transmitted via the anogenital mucosa where it initially infects epidermal keratinocytes and mononuclear phagocytes (MNPs). It then spreads to the dorsal root ganglion via sensory nerve endings, to remain latent for life with periodic reactivation. Currently, there is no cure or vaccine. Initial or recurrent HSV infection can produce serious complications and mediate acquisition of HIV. This review outlines the initial events after the HSV infection of human anogenital mucosa to determine the optimal window to target the virus before it becomes latent. After infection, HSV spreads rapidly within the mid-layers of epidermal keratinocytes in the explanted human inner foreskin. Infected cells produce chemokines, which modulate nectin-1 distribution on the surface of adjacent keratinocytes, facilitating viral spread. Epidermal Langerhans cells and dendritic cells become infected with HSV followed by a “viral relay” to dermal MNPs, which then present viral antigen to T cells in the dermis or lymph nodes. These data indicate the need for interruption of spread within 24 h by diffusible vaccine-induced mediators such as antiviral cytokines from resident immune cells or antibodies. Intradermal/mucosal vaccines would need to target the relevant dermal MNPs to induce HSV-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells.https://www.mdpi.com/1999-4915/16/11/1790herpes simplex virusskingenital mucosaviral spreadkeratinocytesdendritic cells
spellingShingle Hafsa Rana
Naomi R. Truong
Dona R. Sirimanne
Anthony L. Cunningham
Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa
Viruses
herpes simplex virus
skin
genital mucosa
viral spread
keratinocytes
dendritic cells
title Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa
title_full Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa
title_fullStr Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa
title_full_unstemmed Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa
title_short Breaching the Barrier: Investigating Initial Herpes Simplex Viral Infection and Spread in Human Skin and Mucosa
title_sort breaching the barrier investigating initial herpes simplex viral infection and spread in human skin and mucosa
topic herpes simplex virus
skin
genital mucosa
viral spread
keratinocytes
dendritic cells
url https://www.mdpi.com/1999-4915/16/11/1790
work_keys_str_mv AT hafsarana breachingthebarrierinvestigatinginitialherpessimplexviralinfectionandspreadinhumanskinandmucosa
AT naomirtruong breachingthebarrierinvestigatinginitialherpessimplexviralinfectionandspreadinhumanskinandmucosa
AT donarsirimanne breachingthebarrierinvestigatinginitialherpessimplexviralinfectionandspreadinhumanskinandmucosa
AT anthonylcunningham breachingthebarrierinvestigatinginitialherpessimplexviralinfectionandspreadinhumanskinandmucosa